Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.1024 | 45 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.0964 | 47 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.10379 | 47 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.48719 | 59 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.05477 | 47 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.08201 | 43 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.09768 | 44 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.06967 | 46 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.1509 | 49 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.36038 | 55 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.07847 | 46 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.07901 | 47 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.08727 | 46 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.08235 | 46 |